Guide to Biological Medicines- A Focus on Biosimilar Medicines


Biotechnology has enabled the discovery of treatments for a variety of serious diseases.

Worldwide, over 350 million patients have benefited from approved medicines manufactured through biotechnology. Currently, over 650 new biological medicines and vaccines are be developed to treat more than 100 diseases. As the exclusive rights for these biological medicines expire, similar biological medicines, or “biosimilars”, are being developed, with some already available on European markets.